A 15-amino acid pentadecapeptide fragment of Body Protection Compound, studied extensively for its interactions with nitric oxide (NO) pathways, FAK-paxillin signaling, and growth factor modulation.

A synthetic 43-amino acid peptide representing the active region of Thymosin Beta-4, studied for its role in actin sequestration, cell migration, and angiogenesis signaling.

A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied for its effects on gene expression, particularly collagen synthesis genes COL1A1 and COL3A1, and extracellular matrix remodeling.

A selective pentapeptide growth hormone secretagogue that binds the ghrelin receptor (GHSR) with high specificity, studied for its pulsatile GH release pattern without affecting cortisol or prolactin levels.

A synthetic 30-amino acid GHRH analog with Drug Affinity Complex (DAC) technology, studied for its extended half-life and sustained growth hormone-releasing hormone receptor activation.

A modified 83-amino acid analog of insulin-like growth factor 1 with an arginine substitution at position 3, studied for its reduced IGF binding protein affinity and extended biological activity.

A synthetic heptapeptide analog of ACTH(4-10) with a Pro-Gly-Pro C-terminal extension, studied for its modulation of BDNF expression and neurotrophic factor signaling in neural tissue.

A synthetic heptapeptide analog of tuftsin with a Pro-Gly-Pro extension, studied for its modulation of IL-6 expression, enkephalin metabolism, and GABA receptor interactions.

A triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously, studied for its unique tri-receptor activation profile and metabolic signaling effects.

A small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), studied for its effects on cellular NAD+ salvage pathway regulation and adipocyte metabolism.

A 16-amino acid mitochondrial-derived peptide encoded within the 12S rRNA gene, studied for its AMPK activation, nuclear translocation, and regulation of the folate-methionine cycle.

A 28-amino acid peptide originally isolated from thymic tissue, studied for its activation of toll-like receptors (TLR2, TLR9), dendritic cell maturation, and T-cell differentiation signaling.

A C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte stimulating hormone (α-MSH), studied for its NF-κB pathway modulation and melanocortin receptor interactions.

A tripeptide (γ-glutamyl-cysteinyl-glycine) that serves as the cell's primary endogenous antioxidant, studied for its role in Phase II detoxification, redox signaling, and glutathione peroxidase enzyme systems.

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin extract, studied for its activation of telomerase reverse transcriptase (hTERT) and effects on telomere length maintenance.

Nicotinamide adenine dinucleotide, a critical coenzyme present in every living cell, studied for its role in sirtuin activation, PARP-mediated DNA repair, and mitochondrial electron transport chain function.

A cell-permeable tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that concentrates 1000-fold at the inner mitochondrial membrane, studied for its cardiolipin interactions and electron transport chain optimization.

A synthetic 44-amino acid GHRH analog with a trans-3-hexenoic acid modification, the only FDA-approved GHRH analog, studied for its pituitary GH-releasing activity and effects on visceral adipose tissue.

A cyclic heptapeptide melanocortin receptor agonist (MC3R/MC4R), the only FDA-approved melanocortin-based compound, studied for its central nervous system melanocortin pathway activation.

A cyclic lactam analog of α-MSH that acts as a non-selective melanocortin receptor agonist (MC1R-MC5R), studied for its melanogenesis stimulation and melanocortin system pharmacology.